ARRY

Array Biopharma Inc
ARRY

Overview Fund Activity
Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

191 hedge funds and large institutions have $2.56B invested in Array Biopharma Inc in 2017 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 75 increasing their positions, 57 reducing their positions, and 28 closing their positions.

Holders
191
Holders Change
+7
Holders Change %
+3.8%
% of All Funds
4.34%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.16%
New
35
Increased
75
Reduced
57
Closed
28
Calls
$44M
Puts
$22.5M
Net Calls
+$21.5M
Net Calls Change
+$20.1M

Top Buyers

1
BI
1
BVF Inc
California
$111M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$278M
3
State Street
3
State Street
Massachusetts
$119M
4
BlackRock
4
BlackRock
New York
$195M
5
EC
5
EcoR1 Capital
California
$36.9M

Top Sellers

1
O
1
OrbiMed
New York
$97.6M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$73.1M
3
PC
3
PointState Capital
New York
$5.25M
4
Citadel Advisors
4
Citadel Advisors
Florida
$17.3M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$13.7M
Name Market Value Shares Shares
Change 		Shares
Change %
AG
26
Artal Group
Luxembourg
$19.2M 1,500,000 – –
Deutsche Bank
27
Deutsche Bank
Germany
$17.7M 1,381,459 -11,599 -0.8%
Citadel Advisors
28
Citadel Advisors
Florida
$17.3M 1,349,285 -1,449,940 -52%
TA
29
Teachers Advisors
New York
$16.9M 1,319,624 +45,401 +4%
EP
30
Eversept Partners
New York
$15.8M 1,237,803 +1,237,803 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$15.6M 1,219,240 -172,853 -12%
PAM
32
Panagora Asset Management
Massachusetts
$15.1M 1,176,445 -48,939 -4%
Two Sigma Investments
33
Two Sigma Investments
New York
$13.7M 1,069,937 -1,143,781 -52%
Handelsbanken Fonder
34
Handelsbanken Fonder
Sweden
$13.2M 1,033,000 +465,000 +82%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$12.9M 1,008,216 +33,871 +3%
Charles Schwab
36
Charles Schwab
California
$12.3M 961,894 +173,892 +22%
Goldman Sachs
37
Goldman Sachs
New York
$11.8M 921,953 -527,678 -36%
TCIM
38
TIAA CREF Investment Management
New York
$10.6M 828,739 +70,019 +9%
Renaissance Technologies
39
Renaissance Technologies
New York
$9.12M 712,671 +712,671 New
CAM
40
Cormorant Asset Management
Massachusetts
$8.96M 700,000 -200,000 -22%
CS
41
Candriam SCA
Luxembourg
$6.91M 540,000 -204,000 -27%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$6.67M 520,780 -118,774 -19%
Barclays
43
Barclays
United Kingdom
$6.65M 519,712 -290,376 -36%
CI
44
Cambiar Investors
Colorado
$6.49M 507,070 -123,057 -20%
RPAM
45
Rhenman & Partners Asset Management
Sweden
$6.44M 503,059 -146,941 -23%
GTC
46
Ghost Tree Capital
New York
$6.4M 500,000 +500,000 New
IBT
47
International Biotechnology Trust
United Kingdom
$6.11M 477,500 +230,000 +93%
6CM
48
683 Capital Management
New York
$5.76M 450,000 -50,000 -10%
Bank of America
49
Bank of America
North Carolina
$5.26M 410,764 +252,940 +160%
PC
50
PointState Capital
New York
$5.25M 409,800 -1,475,300 -78%
1
2
3 4 5